http://orcid.org/0000-0002-2639-1180
Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Udaya S Tantry, Karsten Schror, Eliano Pio Navarese, Young-Hoon Jeong, Jacek Kubica, Kevin P Bliden & Paul A Gurbel. (2021) Aspirin as an Adjunctive Pharmacologic Therapy Option for COVID-19: Anti-Inflammatory, Antithrombotic, and Antiviral Effects All in One Agent. Journal of Experimental Pharmacology 13, pages 957-970.
Read now
Read now
Sebastian Schloer, Jonas Goretzko, Alexander Kühnl, Linda Brunotte, Stephan Ludwig & Ursula Rescher. (2019) The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo. Emerging Microbes & Infections 8:1, pages 80-93.
Read now
Read now
Articles from other publishers (19)
Jong Hoon Lee, Badar Kanwar, Asif Khattak, Jenny Balentine, Ngoc Huy Nguyen, Richard E. Kast, Chul Joong Lee, Jean Bourbeau, Eric L. Altschuler, Consolato M. Sergi, Tuan Ngoc Minh Nguyen, Sangsuk Oh, Mun-Gi Sohn & Michael Coleman. (2022) COVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs. International Journal of Molecular Sciences 23:21, pages 13260.
Crossref
Crossref
Johannes Jungwirth, Clio Häring, Sarah König, Liane Giebeler, Heena Doshi, Christian Brandt, Stefanie Deinhardt-Emmer, Bettina Löffler & Christina Ehrhardt. (2022) D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir. International Journal of Molecular Sciences 23:13, pages 6880.
Crossref
Crossref
Helga Rübsamen‐Schaeff & Helmut BuschmannOliver Planz. 2022. New Drug Development for Known and Emerging Viruses. New Drug Development for Known and Emerging Viruses
59
96
.
Udaya S. Tantry, Kevin P. Bliden & Paul A. Gurbel. (2022) Further evidence for the use of aspirin in COVID-19. International Journal of Cardiology 346, pages 107-108.
Crossref
Crossref
Bernadette Glatthaar-Saalmüller, Armin Saalmüller & Kerstin H. Mair. (2022) Anti-viral activity of acetylsalicylic acid against human rhinovirus 14 infection involves suppression of VP3 expression and infection-dependent down-regulation of CD54. Current Research in Virological Science 3, pages 100022.
Crossref
Crossref
Jack S. Bell, Gregory Y. H. Lip & Riccardo Proietti. 2022. Cardiovascular Complications of COVID-19. Cardiovascular Complications of COVID-19
331
349
.
B. Mercorelli & A. Loregian. 2021. Antiviral Discovery for Highly Pathogenic Emerging Viruses. Antiviral Discovery for Highly Pathogenic Emerging Viruses
232
255
.
Stephan Ludwig, Eike R. Hrincius & Yvonne Boergeling. (2021) The Two Sides of the Same Coin—Influenza Virus and Intracellular Signal Transduction. Cold Spring Harbor Perspectives in Medicine 11:1, pages a038513.
Crossref
Crossref
Olivier Terrier & Anny Slama-Schwok. 2021. Antiviral Drug Discovery and Development. Antiviral Drug Discovery and Development
195
218
.
Ralf Kircheis, Emanuel Haasbach, Daniel Lueftenegger, Willm T. Heyken, Matthias Ocker & Oliver Planz. (2020) NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients. Frontiers in Immunology 11.
Crossref
Crossref
Vera Ulyanova, Raihan Shah Mahmud, Alexander Laikov, Elena Dudkina, Maria Markelova, Ahmed Mostafa, Stephan Pleschka & Olga Ilinskaya. (2020) Anti-Influenza Activity of the Ribonuclease Binase: Cellular Targets Detected by Quantitative Proteomics. International Journal of Molecular Sciences 21:21, pages 8294.
Crossref
Crossref
Vanessa Bianconi, Francesco Violi, Francesca Fallarino, Pasquale Pignatelli, Amirhossein Sahebkar & Matteo Pirro. (2020) Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?. Drugs 80:14, pages 1383-1396.
Crossref
Crossref
Paul A. Gurbel, Kevin P. BlidenKarsten Schrör. (2020) Can an Old Ally Defeat a New Enemy?. Circulation 142:4, pages 315-317.
Crossref
Crossref
Janine J. Wilden, Andre van Krüchten, Lutz Gieselmann, Eike R. Hrincius, Stefanie Deinhardt-Emmer, Karoline F. Haupt, Hannah F. Preugschas, Silke Niemann, Stephan Ludwig & Christina Ehrhardt. (2020) The influenza replication blocking inhibitor LASAG does not sensitize human epithelial cells for bacterial infections. PLOS ONE 15:5, pages e0233052.
Crossref
Crossref
Ekta Shukla & Radha Chauhan. (2019) Host-HIV-1 Interactome: A Quest for Novel Therapeutic Intervention. Cells 8:10, pages 1155.
Crossref
Crossref
Tobias Welte. (2019) Influenza – jeder kennt die „Grippe“ und doch wird sie immer noch unterschätztInfluenza—everybody knows the “flu” but the threat it is still underestimated. Der Pneumologe 16:4, pages 215-231.
Crossref
Crossref
Andrés Pizzorno, Blandine Padey, Olivier Terrier & Manuel Rosa-Calatrava. (2019) Drug Repurposing Approaches for the Treatment of Influenza Viral Infection: Reviving Old Drugs to Fight Against a Long-Lived Enemy. Frontiers in Immunology 10.
Crossref
Crossref
Ahmed Mostafa, Elsayed Abdelwhab, Thomas Mettenleiter & Stephan Pleschka. (2018) Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview. Viruses 10:9, pages 497.
Crossref
Crossref
Fryad Rahman, Mohammad Chebbo, Noémie Courtin, Aurelien Fotso Fotso, Marie-Christine Alessi & Béatrice Riteau. (2018) The Annexin A1 Receptor FPR2 Regulates the Endosomal Export of Influenza Virus. International Journal of Molecular Sciences 19:5, pages 1400.
Crossref
Crossref